Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

PURPOSE: Aromatase inhibitors (AIs) are effective for treatment of hormone receptor–positive breast cancer, but adherence and persistence with therapy are poor. Predictors of treatment discontinuation are not clearly defined. It is unknown whether patients with intolerable toxicity from one AI are a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Henry, N. Lynn, Azzouz, Faouzi, Desta, Zereunesay, Li, Lang, Nguyen, Anne T., Lemler, Suzanne, Hayden, Jill, Tarpinian, Karineh, Yakim, Elizabeth, Flockhart, David A., Stearns, Vered, Hayes, Daniel F., Storniolo, Anna Maria
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2012
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341106/
https://ncbi.nlm.nih.gov/pubmed/22331951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.0261
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki